Other benign neoplasm of skin, unspecified
ICD-10 D23.9 is a billable code used to indicate a diagnosis of other benign neoplasm of skin, unspecified.
D23.9 refers to other benign neoplasms of the skin that do not fall into more specific categories. These neoplasms can arise from various skin cells, including keratinocytes, melanocytes, and fibroblasts, and may present as lesions that are typically asymptomatic. Common examples include dermatofibromas, seborrheic keratosis, and lipomas. While these growths are generally non-cancerous and do not metastasize, they can cause cosmetic concerns or discomfort depending on their size and location. Diagnosis is often made through clinical examination, and in some cases, a biopsy may be performed to confirm the benign nature of the lesion. Management usually involves monitoring, but surgical excision may be indicated for symptomatic lesions or for cosmetic reasons. Follow-up care is essential to ensure that any changes in the lesion are noted, and to rule out the development of malignant changes over time.
Detailed descriptions of the lesion, including size, location, and appearance, along with any relevant patient history.
Evaluation of a patient with a new skin lesion, follow-up of previously diagnosed benign neoplasms, and management of symptomatic lesions.
Ensure that the documentation clearly states the benign nature of the lesion to avoid misclassification.
Comprehensive history and physical examination notes, including any previous malignancies and family history.
Assessment of skin lesions in patients with a history of skin cancer, and monitoring for changes in benign lesions.
Differentiating between benign and malignant lesions is crucial; thorough documentation is necessary to support coding.
Used when a benign neoplasm is excised for symptomatic relief or cosmetic reasons.
Document the size, location, and type of lesion excised.
Dermatologists should ensure that the excision is well-documented to support the procedure.
Document the characteristics of the lesion, including size, location, and any symptoms. If a biopsy is performed, include the results to confirm the benign nature of the lesion.
